Low serine-glycine-one-carbon pathway activity defines purine salvage dependence in neuroblastoma
Year: 2026
Type: preprint
Abstract: MYCN amplification promotes serine-glycine-one-carbon (SGOC) metabolism in neuroblastoma, creating an intrinsic difference in SGOC activity between MYCNamplified and non-MYCN-amplified high-risk tumors. This metabolic distinction provides a model to investigate how SGOC activity shapes purine metabolism. Here, we show that non-MYCN-amplified neuroblastoma cell lines exhibit lower SGOC pathway activity and are more resistant to pharmacologic suppression of SGOC metabolism by SHMT inhibition under serine- and glycine-deprived conditions. Stable-isotope tracing revealed that non-MYCN-amplified cells exhibited lower contribution of serine-derived glycine and one-carbon units to de novo purine synthesis but elevated basal hypoxanthine and adenine salvage. These cells also showed greater preservation of adenylate pools during SHMT inhibition. Genetic depletion of APRT or HPRT1 preferentially impaired proliferation of non-MYCN-amplified cells, demonstrating increased salvage dependence. SHMT inhibition increased purine salvage, providing additional evidence that suppression of SGOC metabolism shifts purine production toward salvage. We also identify methionine salvage as an endogenous source of adenine that supports proliferation during SHMT inhibition through an MTAP-adenine-APRT axis. Together, these findings establish SGOC pathway activity as an intrinsic determinant of whether cells preferentially rely on de novo purine synthesis or purine salvage and identify salvage dependence as a potential therapeutic vulnerability of low-SGOC tumors.
Institution: University of Alabama at Birmingham
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G1012556710, G1164661550, G1284175734, G317886719, RNA epigenetic regulation of cancer metabolism, G4159268500, G5474901080, METABOLIC REGULATION OF METASTATIC POTENTIAL THROUGH MRNA TRANSLATION, Interaction between the Epitranscriptome and Metabolism in L-2HG Driven Kidney Cancer, Linking nucleotide and amino acid metabolism to cholesterol synthesis by MYCN
OpenAlex ID: W7236834066
